Avecho Biotechnology Ltd

AVE

Company Profile

  • Business description

    Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.

  • Contact

    Unit A8, 2A Westall Road
    Clayton
    MelbourneVIC3168
    AUS

    T: +61 390025000

    https://www.avecho.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    34

Stocks News & Analysis

stocks

Progress in UK expansion for undervalued ASX share

Guidance reaffirmed and UK implementation on track.
stocks

The sectors set to soar on government spending

Governments worldwide love to spend more money, and there are no signs that it will change any time soon.
stocks

Chart of the Week: How private companies are reshaping public markets

Our latest take from the US Manager Research team.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,071.2019.30-0.21%
CAC 408,074.236.700.08%
DAX 4024,049.74100.630.42%
Dow JONES (US)47,397.02311.780.66%
FTSE 1009,777.0862.120.64%
HKSE25,935.4116.99-0.07%
NASDAQ23,614.15265.511.14%
Nikkei 22550,212.271,284.93-2.50%
NZX 50 Index13,620.9815.020.11%
S&P 5006,824.5152.960.78%
S&P/ASX 2008,802.007.80-0.09%
SSE Composite Index3,969.259.060.23%

Market Movers